AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 241 min read$AMRZ

Amrize Ltd (AMRZ): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Amrize Ltd (AMRZ) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers.

Original reporting
SEC EDGAR 8-K
Published Aug 24, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefCorporate actions
Primary signal
$AMRZ
Neutral
high confidence
Mentioned
$AMRZ
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AMRZNeutralLow
01

Why it matters

The filing is a routine corporate governance update with limited trading relevance.

02

Market read

Low relevance for traders; no material financial information disclosed.

03

What to watch

Potential future strategic direction changes if new directors bring different expertise.

Relevance 6/10Novelty 3/10Timing: filing date 2026‑08‑24

Background

Amrize Ltd filed a Form 8‑K detailing changes to its board and executive team.

Company-level read

Ticker impact

$AMRZNeutralHigh confidence
Context

SEC Form 8‑K reports departure and election of directors/officers for Amrize Ltd.

Expected impact

little to no short‑term price movement expected

Evidence & confidence

Director turnover is routine and disclosed without material numbers or strategic shifts.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

Unlikely to affect stock price; focus on larger catalysts.

Key entities

  • company
    Amrize Ltd

    Issuer of the Form 8‑K

Read at source← All news

Related articles

AUG 14
$AMRZMedAI 8/10

Amrize (AMRZ) Q2 2026 Earnings Call Transcript

Amrize AG (AMRZ) reported Q2 2026 revenue of $3.49B, up 8.6%, and net income of $476M, up 14.4%, with adjusted EBITDA of $986M. Management raised fiscal 2026 revenue guidance to $12.5B-$12.7B but revised adjusted EBITDA to $3.1B-$3.2B due to oil-driven cost inflation. The company cited data center and infrastructure demand.

fool.com6 min
AUG 10
$AMRZMedAI 8/10

Amrize Q2 EPS misses $0.94 estimate as costs weigh on margins

Amrize (NYSE: AMRZ) reported Q2 2026 adjusted EPS of $0.88, below the $0.94 consensus estimate. Revenue rose 8.51% to $3.494 billion, beating the $3.365 billion expectation. Net income increased 14.4% to $476 million. The company raised FY2026 revenue guidance to $12.5B-$12.7B but lowered adjusted EBITDA guidance to $3.1B-$3.2B due to cost inflation.

scanx.trade6 min
AUG 10
$AMRZMed

RBC Downgrades Amrize After A Rare Q2 Miss

RBC downgraded Amrize after a rare Q2 miss and reduced guidance, citing a timing mismatch between input-cost increases and the full pass-through of surcharges and price hikes. RBC cut 2026-2028 EBITDA estimates by 4%, 6%, and 7% and EPS by 12%, 14%, and 15%, lowering its stock rating to underperform and price target to $48 from $60.

finimize.com4 min
AUG 7
$AMRZMedAI 8/10

Amrize Q2 Earnings Call Highlights

Amrize (AMRZ) reported Q2 revenue up 8.6% and adjusted EBITDA up 5.8% to $986 million, with net income up 14.4%, citing demand across data centers, energy and infrastructure. Higher freight, diesel and raw-material costs pressured margins. The company raised 2026 guidance: revenue $12.5B-$12.7B and adjusted EBITDA $3.1B-$3.2B, citing pricing lag and inflation.

tradingview.com6 min